Dapagliflozin 5 Zydus & Dapagliflozin 10 Zydus 5 mg/ 10 mg Tablet
PDF Leaflet Revision Date: 03/08/2022
Clinical Summary
Quick overview from the medicine insert
Indication
Improves glycaemic control in adults with type 2 diabetes mellitus.
Dosage (summary)
10 mg once daily for adults; lower doses may be needed for insulin or secretagogue users.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Insulin
- Sulphonylureas
- Diuretics
Contraindications
- Hypersensitivity
- Moderate to severe renal impairment
- Type 1 diabetes
- Pregnancy
- Breastfeeding
Common side effects
- Genital infections
- Urinary tract infections
- Dizziness
Counselling Points
- Monitor for signs of ketoacidosis
- Stay hydrated
- Report genital infections immediately
Serious warnings
- Risk of ketoacidosis
- Volume depletion
- Fournier's gangrene
Important Disclaimer
The Dapagliflozin 5 Zydus & Dapagliflozin 10 Zydus 5 mg/ 10 mg Tablet professional information leaflet below is the property of Zydus Healthcare Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
